KLOW (80MG UNIT)
Description
BPC157 +TB500 + GHK-CU + KPV (10+10+50+10) BLEND
BPC157+TB500+GHK-CU+KPV— Research Grade Peptide
Overview
KLOW is a research-grade peptide combination of BPC157, TB500 (Thymosin β4 acetate), GHK-Cu, and KPV formulated for in vitro investigation of coordinated cellular synthesis, endothelial dynamics, biochemical response signaling, and cytoskeletal remodeling. Supplied as a lyophilized blend for stability and analytical precision; QC-verified for identity and batch purity
Research context
Intended for non-clinical in vitro studies, KLOW is designed to .probe combined mechanisms of cellular proliferation, endothelial dynamics, cell migration, biochemical response modulation, and extracellular matrix/cytoskeletal interactions, and to model potential synergistic effects between the components in controlled laboratory assays.
Product Information
- Product nameKLOW (BPC157 + TB500 + GHK-Cu + KPV)
- ContentsBPC157, TB500, GHK-Cu, KPV — ratio and unit size as labeled
- AppearanceWhite to off-white lyophilized powder
- FormLyophilized solid blend
- Purity>99% per component (HPLC verified)
Storage & Handling
- Store at −20 °C; protect from moisture and light.
- Lyophilized for stability; avoid repeated freeze–thaw cycles after reconstitution.
- Follow institutional protocols for reconstitution and aseptic handling.
Research Applications
- In vitro cellular migration and scratch assays
- Endothelial angiogenesis and tube-formation studies
- Cell migration and cytoskeletal dynamics assays
- Biochemical response and epithelial integrity signaling models
- Combination mechanism-of-action and pathway interaction analyses
Legal & Safety
For laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or veterinary use. No therapeutic, diagnostic, or dosing claims are made. This product has not been evaluated by the U.S. Food and Drug Administration (FDA) and is not intended to diagnose, treat, cure, or prevent any disease.
